YIH
ISEE

Y-Intercept (HK)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Y-Intercept (HK)’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,309
Closed -$364K – 1446
2022
Q3 		$364K Buy
+20,309
New +$267K 0.04% 640

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Y-Intercept (HK)'s ISEE Position: Q4 2022 in Review

Y-Intercept (HK) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 20,309 shares — an estimated $364K sold.

Y-Intercept (HK) first reported a position in ISEE in Q3 2022 and held it in 1 quarter. The position peaked at $364K in Q3 2022. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • Y-Intercept (HK) reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Y-Intercept (HK) sold 20,309 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $364K.
  • Y-Intercept (HK) first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Y-Intercept (HK)'s IVERIC bio, Inc. Common Stock position peaked at $364K in Q3 2022.
  • 225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Y-Intercept (HK)'s 13F filing for Q4 2022, filed 14 Feb 2023.